These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 32595361)

  • 1. Gut-lung axis and dysbiosis in COVID-19.
    Aktas B; Aslim B
    Turk J Biol; 2020; 44(3):265-272. PubMed ID: 32595361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathy in COVID-19 associated with dysbiosis-related inflammation.
    Aktas B; Aslim B
    Turk J Biol; 2021; 45(4):390-403. PubMed ID: 34803442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermodulation of gut-lung axis microbiome and the implications of biotics to combat COVID-19.
    S A; K G; A AM
    J Biomol Struct Dyn; 2022; 40(24):14262-14278. PubMed ID: 34699326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
    de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
    Front Immunol; 2021; 12():635471. PubMed ID: 33717181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota and Covid-19- possible link and implications.
    Dhar D; Mohanty A
    Virus Res; 2020 Aug; 285():198018. PubMed ID: 32430279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
    Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between COVID-19 and the gut-brain axis: a gut feeling.
    Kalam N; Balasubramaniam VRMT
    Postgrad Med J; 2024 Jul; 100(1186):539-554. PubMed ID: 38493312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
    Xiang H; Liu QP
    World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of SARS-CoV-2 infection by diet-modulated gut microbiota.
    Tieu V; Tibi S; Ling J
    Front Cell Infect Microbiol; 2023; 13():1167827. PubMed ID: 37457959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 - gastrointestinal and gut microbiota-related aspects.
    Kaźmierczak-Siedlecka K; Vitale E; Makarewicz W
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10853-10859. PubMed ID: 33155247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of the gut microbiota in severe SARS-CoV-2 infection.
    Liu Y; Kuang D; Li D; Yang J; Yan J; Xia Y; Zhang F; Cao H
    Cytokine Growth Factor Rev; 2022 Feb; 63():98-107. PubMed ID: 35131164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of the Gut-Lung Axis in COVID-19 Infections and Its Modulation to Improve Clinical Outcomes.
    Chen J; Vitetta L
    Front Biosci (Schol Ed); 2022 Aug; 14(3):23. PubMed ID: 36137978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychiatric Ramifications of COVID-19: Short-Chain Fatty Acid Deficiency and Disturbance of Microbiota-Gut-Brain Axis Signaling.
    Sajdel-Sulkowska EM
    Biomed Res Int; 2021; 2021():7880448. PubMed ID: 34651049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and gut immunomodulation.
    Roy K; Agarwal S; Banerjee R; Paul MK; Purbey PK
    World J Gastroenterol; 2021 Dec; 27(46):7925-7942. PubMed ID: 35046621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID.
    Ancona G; Alagna L; Alteri C; Palomba E; Tonizzo A; Pastena A; Muscatello A; Gori A; Bandera A
    Front Immunol; 2023; 14():1080043. PubMed ID: 36969243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Drug Targets for Gut Microbiota Biocorrection during the SARS-CoV-2 Pandemic: A Systematic Review.
    Sankova MV; Nikolenko VN; Oganesyan MV; Bakhmet AA; Gavryushova LV; Sankov SV; Sinelnikov MY
    Curr Drug Targets; 2022; 23(11):1099-1125. PubMed ID: 35440305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review.
    Liu TFD; Philippou E; Kolokotroni O; Siakallis G; Rahima K; Constantinou C
    Infection; 2022 Aug; 50(4):815-847. PubMed ID: 34671922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19.
    Jin B; Singh R; Ha SE; Zogg H; Park PJ; Ro S
    World J Gastroenterol; 2021 May; 27(19):2341-2352. PubMed ID: 34040326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV.
    Ishizaka A; Koga M; Mizutani T; Yamayoshi S; Iwatsuki-Horimoto K; Adachi E; Suzuki Y; Kawaoka Y; Yotsuyanagi H
    BMC Microbiol; 2024 Jan; 24(1):6. PubMed ID: 38172680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring gut-lung axis crosstalk in SARS-CoV-2 infection: Insights from a hACE2 mouse model.
    Zhang Y; Ma Y; Sun W; Zhou X; Wang R; Xie P; Dai L; Gao Y; Li J
    J Med Virol; 2024 Jan; 96(1):e29336. PubMed ID: 38193530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.